Epiminder
Australia - MelbourneBiotechnology
Focus: Epiminder is an Australian biotech company specializing in epilepsy monitoring devices, specifically the Minder System for non-invasive seizure detection. The company operates as a pre-revenue or early-stage medical device innovator in the neurology space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Epiminder
AI assessmentNot HiringNo open roles listed right now. Follow Epiminder to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Previous receipt of the Minder System
EpilepsyClinical Trials (1)
NCT07110454Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
N/AHelp build intelligence for Epiminder
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.